anna caldwell, Author at European Medical Journal - Page 9 of 16

Exercise Fails to Improve Cognitive Function in New Study

Large clinical trial shows no improvement in cognitive function from exercise or intensive vascular risk reduction in older adults.

BRCA1 Mutation Study Reveals Oestrogen DNA Damage

Oestrogen and environmental exposures drive DNA damage in BRCA1 mutation cells, while Indole-3 carbinol shows promise in reducing genomic instability.

First Human Case of Bird Flu Imported in EU

Italian health authorities have been alerted of the first human case of avian influenza A(H9N2) in the EU, identified in the Lombardy Region.

“New Lineage” of COVID-19 Reported in 23 Countries

An emerging and “highly divergent” SARS-CoV-2 variant has now been reported in 23 countries since first detection in November 2024, CDC reported this month.

Metformin: Hidden Brain Pathway to Lower Blood Sugar Revealed

Scientists have discovered a previously unknown neural pathway behind the antidiabetic effects of metformin, a standard first-line treatment for Type 2 diabetes.

England’s Resident Doctors Announce Six-Day Strike

Resident doctors in England have announced six days of industrial action following a break down of negotiations with the government over pay erosion and job shortages.

Depression Severity Linked to Cardiovascular Risk in Diabetes

The analysis showed that patients with greater depression severity consistently had higher FRS values, indicating increased cardiovascular risk.

New Hidradenitis Suppurativa Treatment After Failed Anti-TNF Therapy

A phase 2 trial shows promising results for hidradenitis suppurativa treatment, offering hope for patients with limited options after anti TNF therapy failure.

Barriers to Cancer Prevention in EU Revealed

The International Agency for Research on Cancer has revealed the structural and social barriers stopping people from adopting cancer preventive behaviours in the EU.

Europe Misses One in Five Tuberculosis Cases

Tens of thousands of people remain undiagnosed while Europe’s multidrug-resistant tuberculosis rates are up to seven times the global average.